LELizbeth Estrada-Capetillo

Lizbeth Estrada-Capetillo

*This is an algorithmically generated author record based on publicly available information.

Lizbeth Estrada-Capetillo has a total of 70 co-authors. Here are the top co-authors by number of shared publications:

  • Amaya Puig-Kröger

    Laboratorio de Inmuno-Metabolismo, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

    3 shared publications
  • Carlos Abud-Mendoza

    Hospital Central & Facultad de Medicina Universidad Autónoma de San Luis Potosí San Luis Potosí Mexico

    3 shared publications
  • Blanca Soler Palacios

    Department of Immunology and Oncology, National Center for Biotechnology, Consejo Superior de Investigaciones Científicas (CSIC), 28049 Madrid, Spain

    2 shared publications
  • Cristina Municio

    Laboratorio de Inmuno-Metabolismo, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain

    2 shared publications
  • Esther Layseca-Espinosa

    Molecular and Translational Medicine Section, Research Center for Health Sciences and Biomedicine, Universidad Autónoma de San Luis Potosí, San Luis Potosi 78210, Mexico

    2 shared publications
  • Lourdes Baranda

    Department of Immunology, Facultad de Medicina, UASLP, Avenue V. Carranza 2405, 78210 San Luis Potosí, SLP, Mexico

    2 shared publications

Latest Publications

  • Open Access

    AB0087 Synovial tissue macrophages polarisation (M1, M2) in patients with undifferentiated arthritismeeting diagnostic criteria for rheumatoid arthritis or psoriatic arthritis along the follow up

    by A. Cuervo Aguilera, S. Fuentelsaz-Romero, L. Estrada-Capetillo, R. Celis, R. Samaniego, J. Ramírez, A. Puig-Kröger, J.D. Cañete

    Background Undifferentiated arthritis (UA) is defined as an inflammatory oligo-or polyarthritis that does not fulfil criteria for a definitive diagnosis. Earlier diagnosis would permits a better functional prognosis. Synovial tissue (ST) macrophages have been associated with disease activity, radiographic erosion and response to therapy in RA. Furthermore, it has been reported that M1 polarised macrophages predominate in RA synovitis, whereas M2 predominate in SpA synovitis.1 Objectives To analyse polarised macrophages (M1 proinflammatory and M2 anti-inflammatory) in ST of patients with UA which evolved to RA or PsA, after a long follow-up, to explore their diagnostic value. Methods To determine the polarisation state of macrophages in ST obtained by arthroscopy from patients with UA that evolved to RA (UA-RA=8) or PsA (UA-PsA=9), the expression of proteins associated to GM-CSF-driven polarisation M1(INHBA, TNFα and MMP12) and M-CSF-driven polarisation M2(CD209) was assessed in ST CD163+macrophages. Patients with established RA(n=12) or PsA(n=10) were included as control. 4 µm cryosections of ST in OCT were blocked for 10 min with 1% human immunoglobulins and incubated with primary (1–5 µg/ml) and secondary antibodies. Imaging was performed with an inverted confocal microscope (SPE, Leica Microsystems) and glycerol immersion objective (ACS-APO 20x/NA 0.60). Single cell mean fluorescence intensity(MFI) was assessed using ImageJ software (National Institutes of Health, Bethesda, MD, USA). At least three random fields were evaluated for each type of ST, quantifying the expression of INHBA, TNF-α, MMP12 and CD209 in all segmented CD163+macrophages. Macrophages density was normalised based on selected tissue area(mm2). After background subtraction, data were plotted using GraphPad software (GraphPad Software, La Jolla, CA, USA). Results CD163+ sublining (SL) macrophages from UA-RA expressed abundantly the INHBA-encoded activin A, whereas TNFα and MMP12 were variably detected. Regarding the M-CSF-associated marker CD209, 2 populations of CD163+ macrophages were found in the SL of UA-RA, CD163+CD209+ and the other CD163+CD209-, with higher than 100 arbitrary units (au) for CD163+CD209+ and lower than 100 au for CD163+CD209-. Similarly, INHBA, MMP12 and TNFα expression and 2 populations of CD209 were detected in CD163+ macrophages from UA-PsA. Macrophage density was also found comparable between UA, with 650/mm2 in UA-RA and 649/mm2 in UA-PsA. Quantification of the above indicated markers in CD163 +ST macrophages from established RA and PsA revealed similar levels of INHBA, TNFα, MMP12 and CD209 than those from UA-RA and UA-PsA. Conclusions This study shows for the first time that the polarisation state of ST CD163+ macrophages in UA progressing to RA and PsA is similar to that of established RA and PsA in terms of INHBA, MMP12, TNFα and CD209 expression. Therefore, the inflammatory polarisation state of macrophages is similar in RA and PsA and it is already detected at the earlier steps. Reference [1] Vandooren B, et al. Arthritis Rheum2009;60(4):966–75. Acknowledgements Financed “Fondo de Investigación Sanitaria”(PI14/00785.JD Cañete)Instituto de Salud Carlos III. Cofinanced BECA FER-2015. Disclosure of Interest None declared


  • Methotrexate selectively targets human proinflammatory macrophages through a thymidylate synthase/p53 axis

    by Cristina Municio, Blanca Soler Palacios, Lizbeth Estrada-Capetillo, Alberto Benguria, Ana Dopazo, Elena García-Lorenzo, Salvador Fernández-Arroyo, Jorge Joven, María Eugenia Miranda-Carús, Isidoro González-Álvaro, et al.

    Objectives Methotrexate (MTX) functions as an antiproliferative agent in cancer and an anti-inflammatory drug in rheumatoid arthritis (RA). Although macrophages critically contribute to RA pathology, their response to MTX remains unknown. As a means to identify MTX response markers, we have explored its transcriptional effect on macrophages polarised by GM-CSF (GM-MØ) or M-CSF (M-MØ), which resemble proinflammatory and anti-inflammatory macrophages found in RA and normal joints, respectively. Methods The transcriptomic profile of both human macrophage subtypes exposed to 50 nM of MTX under long-term and short-term schedules were determined using gene expression microarrays, and validated through quantitative real time PCR and ELISA. The molecular pathway involved in macrophage MTX-responsiveness was determined through pharmacological, siRNA-mediated knockdown approaches, metabolomics for polyglutamylated-MTX detection, western blot, and immunofluorescence on RA and normal joints. Results MTX exclusively modulated gene expression in proinflammatory GM-MØ, where it influenced the expression of 757 genes and induced CCL20 and LIF at the mRNA and protein levels. Pharmacological and siRNA-mediated approaches indicated that macrophage subset-specific MTX responsiveness correlates with thymidylate synthase (TS) expression, as proinflammatory TS+ GM-MØ are susceptible to MTX, whereas anti-inflammatory TSlow/− M-MØ and monocytes are refractory to MTX. Furthermore, p53 activity was found to mediate the TS-dependent MTX-responsiveness of proinflammatory TS+ GM-MØ. Importantly, TS and p53 were found to be expressed by CD163+/TNFα+ GM-CSF-polarised macrophages from RA joints but not from normal synovium. Conclusions Macrophage response to MTX is polarisation-dependent and determined by the TS-p53 axis. CCL20 and LIF constitute novel macrophage markers for MTX responsiveness in vitro.


  • VIP impairs acquisition of the macrophage proinflammatory polarization profile

    by Mar Carrión, Selene Pérez-García, Carmen Martínez, Yasmina Juarranz, Lizbeth Estrada-Capetillo, Amaya Puig-Kröger, Rosa P. Gomariz, Irene Gutiérrez-Cañas

    This study tested the hypothesis that vasoactive intestinal peptide (VIP) is able to modify the macrophage inflammatory profile, thus supporting its therapeutic role in autoimmune diseases. Macrophages are innate immune cells that display a variety of functions and inflammatory profiles in response to the environment that critically controls their polarization. Deregulation between the pro- and anti-inflammatory phenotypes has been involved in different pathologies. Rheumatoid arthritis (RA) is an autoimmune disease, in which macrophages are considered central effectors of synovial inflammation, displaying a proinflammatory profile. VIP is a pleiotropic neuropeptide with proven anti-inflammatory actions. As modulation of the macrophage phenotype has been implicated in the resolution of inflammatory diseases, we evaluated whether VIP is able to modulate human macrophage polarization. In vitro-polarized macrophages by GM-CSF (GM-MØ), with a proinflammatory profile, expressed higher levels of VIP receptors, vasoactive intestinal polypeptide receptors 1 and 2 (VPAC1 and VPAC2, respectively), than macrophages polarized by M-CSF (M-MØ) with anti-inflammatory activities. RA synovial macrophages, according to their GM-CSF-like polarization state, expressed both VPAC1 and VPAC2. In vitro-generated GM-MØ exposed to VIP exhibited an up-regulation of M-MØ gene marker expression, whereas their proinflammatory cytokine profile was reduced in favor of an anti-inflammatory function. Likewise, in GM-MØ, generated in the presence of VIP, VIP somehow changes the macrophages physiology profile to a less-damaging phenotype. Therefore, these results add new value to VIP as an immunomodulatory agent on inflammatory diseases.


  • Bifidobacterium pseudocatenulatum CECT7765 induces an M2 anti-inflammatory transition in macrophages from patients with cirrhosis

    by Alba Moratalla, Esther Caparrós, Oriol Juanola, Kevin Portune, Amaya Puig-Kröger, Lizbeth Estrada-Capetillo, Pablo Bellot, Isabel Gómez-Hurtado, Paula Piñero, Pedro Zapater, et al.


  • Macrophages from the synovium of active rheumatoid arthritis exhibit an activin A‐dependent pro‐inflammatory profile

    by Blanca Soler Palacios, Lizbeth Estrada‐Capetillo, Elena Izquierdo, Gabriel Criado, Concha Nieto, Cristina Municio, Isidoro González‐Alvaro, Paloma Sánchez‐Mateos, Jose Luis Pablos, Angel L Corbí, et al.

    Rheumatoid arthritis (RA) is a chronic inflammatory disease whose pathogenesis and severity correlates with the presence of macrophage‐derived pro‐inflammatory cytokines within the inflamed synovium. Macrophage‐derived cytokines fuel the pathological processes in RA and are targets of clinically successful therapies. However, although macrophage polarization determines cytokine production, the polarization state of macrophages in RA joints remains poorly defined. To dissect the molecular basis for the tissue‐damaging effects of macrophages in RA joints, we undertook the phenotypic and transcriptomic characterization of ex vivo isolated CD14+ RA synovial fluid (RA‐SF) macrophages. Flow cytometry and gene profiling indicated that RA‐SF macrophages express pro‐inflammatory polarization markers (MMP12, EGLN3, CCR2), lack expression of markers associated with homeostatic and anti‐inflammatory polarization (IGF1, HTR2B) and exhibit a transcriptomic profile that resembles the activin A‐dependent gene signature of pro‐inflammatory in vitro‐generated macrophages. In fact, high levels of Smad‐activating activin A were found in RA‐SF and, accordingly, the Smad signalling pathway was activated in ex vivo‐isolated RA‐SF macrophages. In vitro experiments on monocytes and macrophages indicated that RA‐SF promoted the acquisition of pro‐inflammatory markers (INHBA, MMP12, EGLN3, CCR2) but led to a significant reduction in the expression of genes associated with homeostasis and inflammation resolution (FOLR2, SERPINB2, IGF1, CD36), thus confirming the pro‐inflammatory polarization ability of RA‐SF. Importantly, the macrophage‐polarizing ability of RA‐SF was inhibited by an anti‐activin A‐neutralizing antibody, thus demonstrating that activin A mediates the pro‐inflammatory macrophage‐polarizing ability of RA‐SF. Moreover, and in line with these findings, multicolour immunofluorescence evidenced that macrophages within RA synovial membranes (RA‐SM) also express pro‐inflammatory polarization markers whose expression is activin A‐dependent. Altogether, our results demonstrate that macrophages from RA synovial fluids and membranes exhibit an MMP12+ EGLN3+ CCR2+ pro‐inflammatory polarization state whose acquisition is partly dependent on activin A from the synovial fluid. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.


  • Open Access

    Induction of Th17 Lymphocytes and Treg Cells by Monocyte-Derived Dendritic Cells in Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus

    by Lizbeth Estrada-Capetillo, Berenice Hernández-Castro, Adriana Monsiváis-Urenda, Crisol Alvarez-Quiroga, Esther Layseca-Espinosa, Carlos Abud-Mendoza, Lourdes Baranda, Ana Urzainqui, Francisco Sánchez-Madrid, Roberto González-Amaro

    Dendritic cells (DCs) have a key role in the regulation of immune response. We herein explored, in patients with inflammatory diseases, the role of monocyte derived DC’s (mo-DCs) on the generation of Th17 and T regulatory (Treg) lymphocytes. Peripheral blood was obtained from thirty-five patients with rheumatoid arthritis (RA), twelve with systemic lupus erythematosus (SLE), and twenty healthy subjects. Mo-DCs were generated under standard (IL-4/GM-CSF) or tolerogenic (IL-4/GM-CSF plus recombinant P-selectin or PD-1 or IL-10) conditions, and their ability to induce Th17 and Treg lymphocytes was tested. We detected that mo-DCs from patients with RA showed an enhanced release of IL-6 and IL-23 as well as an increased capability to induce Th17 cells. Although mo-DCs from SLE patients also released high levels of IL-6/IL-23, it did not show an increased ability to induce Th17 lymphocytes. In addition, mo-DCs, from patients with RA and SLE generated under the engagement of PSGL-1, showed a defective capability to induce Foxp3+ Treg cells. A similar phenomenon was observed in SLE, when DC’s cells were generated under PDL-1 engagement. Our data indicate that DCs from patients with rheumatic inflammatory disease show an aberrant function that may have an important role in the pathogenesis of these conditions.


  • Expression and Function of Dectin-1 is Defective in Monocytes from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

    by Claudia Salazar-Aldrete, Marta Galán-Díez, Elena Fernández-Ruiz, Perla Niño-Moreno, Lizbeth Estrada-Capetillo, Carlos Abud-Mendoza, Esther Layseca-Espinosa, Lourdes Baranda, Roberto González-Amaro

    The aim of this work was to study the expression and function of the innate immune receptor dectin-1 in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). We studied twenty-six patients with SLE not receiving immunosuppressive therapy, twenty-six patients with RA, and fifteen controls. We found that monocytes from SLE patients showed a diminished expression of dectin-1 compared to healthy controls, and an inverse correlation between percent of dectin-1+ cells and the disease activity score was detected. In addition, cells from SLE patients showed an abnormal calcium flux response induced by dectin-1 ligands as well as an enhanced release of IL-1β, IL-6 and TNF-α, but not IL-23, upon dectin-1 engagement. Monocytes from patients with RA also showed a diminished expression, and a defective function of dectin-1. Our data suggest that dectin-1 receptor defects could contribute to the pathogenesis of autoimmune inflammatory conditions.


  • Decreased blood levels of B lymphocytes and NK cells in patients with systemic lupus erythematosus (SLE) infected with papillomavirus (HPV)

    by C. Abud-Mendoza, E. Cuevas-Orta, E. N. Santillán-Guerrero, M. U. Martínez-Martínez, B. Hernández-Castro, L. Estrada-Capetillo, R. González-Amaro, L. Baranda

    Patients with systemic lupus erythematosus (SLE) show an enhanced risk to develop human papillomavirus (HPV) infection, and aggressive forms of this condition are seen in these patients. The aim of this study was to assess the possible relationship among HPV infection, immunosuppressive therapy and levels of leukocyte subsets in patients with SLE. The following individuals were included in the study: (1) SLE patients under immunosuppressive therapy and with lesions caused by HPV (n = 16); (2) SLE patients under immunosuppressive therapy and no evidence of HPV infection (n = 20); (3) untreated SLE patients with no evidence of HPV infection (n = 7), and; (4) healthy female subjects without evidence of HPV infection (n = 10). Peripheral blood was obtained and the percentages of different lymphocyte subsets were determined by flow cytometry, with the use of the following monoclonal antibodies: CD3, CD4, CD8, CD16, CD19, CD20, CD22, CD56, and CD335 (NKp46). We found that SLE patients under immunosuppressive therapy and with lesions caused by HPV showed significantly lower levels of B lymphocytes and NK cells compared to other groups. In contrast, SLE patients receiving immunosuppressive drugs and with no evidence of HPV infection showed similar levels of B and NK cells than healthy controls. Those patients receiving mycophenolate mofetil (MMF) had a diminished number of B cells, and a positive correlation was detected between the dose of MMF and the number of HPV skin lesions. Our data suggest that therapy of SLE patients with MMF is associated with diminished levels of B and NK cells and an enhanced risk for HPV infection.


  • Open Access

    Human Papillomavirus Immunization Is Associated with Increased Expression of Different Innate Immune Regulatory Receptors

    by V. Colmenares, D. E. Noyola, A. Monsiváis-Urenda, M. Salgado-Bustamante, L. Estrada-Capetillo, R. González-Amaro, L. Baranda

    Human papillomavirus (HPV) is able to inhibit the secretion of gamma interferon (IFN-γ) and the expression of some immune innate cell receptors. Immunoglobulin-like transcript 2 (ILT2) is a regulatory receptor that seems to participate in the pathogenesis of viral infections. We have studied the expression and function of ILT2 and the expression of other NK cell receptors in 23 healthy women before and after immunization with the quadrivalent HPV (type 6/11/16/18) vaccine (Gardasil). Receptor expression was analyzed by flow cytometry in freshly isolated peripheral blood mononuclear cells as well as afterin vitrostimulation with the quadrivalent HPV (type 6/11/16/18) vaccine. In addition, the regulatory function of ILT2 on cell proliferation and IFN-γ production was analyzed. We found a significant increase in the expression of ILT2 by NK and CD3+CD56+lymphocytes and monocytes after quadrivalent HPV (type 6/11/16/18) vaccine immunization. In addition, thein vitrostimulation with the quadrivalent HPV (type 6/11/16/18) vaccine also increased the proportion of CD3−CD56+ILT2+NK cells. Although the inhibitory function of ILT2 on cell proliferation was enhanced after HPV immunization, thein vitroengagement of this receptor did not affect the synthesis of IFN-γ induced by HPV. Finally, a significant increase in the expression of NKG2D, NKp30, and NKp46 by NK and CD3+CD56+lymphocytes was detected after quadrivalent HPV (type 6/11/16/18) vaccine immunization. Our data indicate that HPV immunization is associated with significant changes in the expression and function of different innate immune receptors, including ILT2, which may participate in the protective effect of HPV vaccines.


  • Pattern of expression of apoptosis and inflammatory genes in humans exposed to arsenic and/or fluoride

    by Mariana Salgado-Bustamante, María D. Ortiz-Pérez, Emma Calderón-Aranda, Lizbeth Estrada-Capetillo, Perla Niño-Moreno, Roberto González-Amaro, Diana Portales-Pérez